Marshall Wace’s Vera Therapeutics VERA Stock Holding History

Marshall Wace’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$323K	Buy	+7,531	New	+$281K	﹤0.01%	2689
2025 Q3	–	Sell	-16,872	Closed	-$398K	–	3443
2025 Q2	$398K	Sell	16,872 -172,375	-91%	-$3.88M	﹤0.01%	2220
2025 Q1	$4.55M	Sell	189,247 -647,899	-77%	-$20.8M	0.01%	1111
2024 Q4	$35.4M	Buy	837,146 +253,421	+43%	+$11.2M	0.04%	369
2024 Q3	$25.8M	Buy	583,725 +59,147	+11%	+$2.24M	0.03%	434
2024 Q2	$19M	Buy	524,578 +44,059	+9%	+$1.75M	0.03%	523
2024 Q1	$20.7M	Buy	+480,519	New	+$17.1M	0.03%	500
2023 Q3	–	Sell	-14,699	Closed	-$236K	–	2723
2023 Q2	$236K	Sell	14,699 -30,087	-67%	-$272K	﹤0.01%	2204
2023 Q1	$348K	Buy	+44,786	New	+$346K	﹤0.01%	2244

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Marshall Wace's VERA Position: Q2 2026 in Review

Marshall Wace opened a new position in Vera Therapeutics (VERA) in Q2 2026: 7,531 shares worth $323K. The stake represents ﹤0.01% of the portfolio and ranks #2689 among its holdings. This is a return to the name: Marshall Wace previously reported a position in VERA as recently as Q2 2025.

Marshall Wace first reported a position in VERA in Q1 2023 and has held it in 9 quarters since. The position peaked at $35.4M in Q4 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Marshall Wace held 7,531 shares of Vera Therapeutics worth $323K as of Q2 2026.
Vera Therapeutics was a new Marshall Wace position in Q2 2026.
Vera Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2689 holding.
Marshall Wace first reported a position in Vera Therapeutics in Q1 2023 and has held it in 9 quarters since.
Marshall Wace's Vera Therapeutics position peaked at $35.4M in Q4 2024.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.